Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Citi
Fish and Richardson
Merck
Covington
Queensland Health
Express Scripts
Argus Health
Harvard Business School

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,030,095

« Back to Dashboard

Which drugs does patent 7,030,095 protect, and when does it expire?

Patent 7,030,095 protects NATROBA and is included in one NDA.

This patent has eleven patent family members in eleven countries.
Summary for Patent: 7,030,095
Title:Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
Abstract:The present invention relates to composition and methods for administering compositions in solutions for killing adult lice and the ova comprising water, PVM/MA Decadiene crosspolymers, propylene glycol, a mixture of cetyl and stearyl alcohols, Ceteareth-20; stearalkonium chloride; benzyl alcohol; hexylene glycol; pentylene glycol, isopropyl alcohol; a mixture of spinosyn A and spinosyn D in a weight ratio of 80:20, BHT; and sodium hydroxide.
Inventor(s): Janssen; Herwig (Princeton, NJ), Ho; Kie (Princeton, NJ), Nystrand; Glenn (Lebanon, NJ), Williams; Dexter (Dayton, NJ), Lamb; C. Scott (Doylestown, PA)
Assignee: Johnson & Johnson Consumer Companies, Inc. (Skillman, NJ)
Application Number:10/230,460
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Drugs Protected by US Patent 7,030,095

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Parapro Llc NATROBA spinosad SUSPENSION;TOPICAL 022408-001 Jan 18, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,030,095

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,727,228 Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 7,030,095

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Mexico PA02004088 ➤ Try a Free Trial
South Korea 20020083144 ➤ Try a Free Trial
Japan 2003012522 ➤ Try a Free Trial
Spain 2260391 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Express Scripts
Deloitte
Merck
Cantor Fitzgerald
Healthtrust
US Department of Justice
Cipla
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.